ABHI (Association of British Healthcare Industries) rejects new UK assessment rules
This article was originally published in Clinica
The Association of British Healthcare Industries (ABHI) has rejected the new methods for assessing medical technology in the UK. While welcoming the broad principles of the new National Institute for Clinical Excellence (NICE) - "faster access to modern treatment" - it argues that its methods are not appropriate to the medical systems industry and that it could hold many drawbacks, including delays in the introduction of new technology, static guidelines for clinical procedures and the threat of rationing.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.